The Commonwealth of Pennsylvania Public School Empls Retrmt SYS reduced its stake in Targa Resources (NYSE:TRGP) by 1.4% in the fourth quarter, selling 5,152 shares and holding 366,389 shares valued at $67.6 million. Despite missing EPS and revenue estimates in its latest quarter, Targa Resources increased its quarterly dividend to $1.25 per share, resulting in an annualized payout of $5.00 and a 2.0% yield. Analyst ratings for TRGP remain largely positive, with 15 Buy and 3 Hold ratings, and a consensus target price of $269.21.

The Commonwealth of Pennsylvania Public School Employees' Retirement System (PSERS) reduced its stake in Uber Technologies by 3.5% in Q4, but still holds 483,315 shares valued at $39.49 million. Uber reported strong Q1 earnings, beating analyst estimates, and provided positive Q2 2026 guidance. Recent business developments, including new partnerships and services, could further influence Uber's stock performance, though concerns exist regarding rising costs and potential acquisitions.

The Commonwealth of Pennsylvania Public School Employees' Retirement System (PSERS) has reduced its stake in The Goldman Sachs Group, Inc. by 4.0%, selling 2,929 shares to now hold 69,765 shares valued at approximately $61.3 million. This divestment occurred despite Goldman Sachs reporting strong quarterly results with EPS of $17.55 and revenue of $17.23 billion, surpassing analyst expectations, and announcing a quarterly dividend of $4.50 per share. Other institutional investors have shown mixed activity, with some increasing and others decreasing their holdings in the company.

The Commonwealth of Pennsylvania Public School Empls Retrmt SYS reduced its stake in Walmart Inc. by 3.2% in Q4, selling 34,023 shares but retaining over 1 million shares valued at about $113.6 million. Despite recent executive departures and insider sales, Walmart reported solid Q1 results with revenue of $177.75 billion and EPS of $0.66, also providing optimistic forward guidance. Analysts largely maintain a "Buy" rating on the stock with an average price target of $138.85.

Eurizon Capital SGR S.p.A. has acquired a new stake of 227,730 shares in American Tower Corporation (NYSE:AMT) during the fourth quarter, valued at approximately $40.01 million. Several other institutional investors also adjusted their positions in the company. American Tower reported strong quarterly earnings, beating analyst expectations, and announced a quarterly dividend of $1.79 per share, leading to an annualized dividend of $7.16 and a dividend yield of 3.8%.

The Commonwealth of Pennsylvania Public School Employees' Retirement System reduced its stake in American Express (AXP) by 4.1% in Q4, selling 5,363 shares but still holding 124,980 shares valued at $46.2 million. Analyst sentiment is mixed, with a "Hold" consensus and an average target of $359.05. American Express reported strong Q1 earnings, beating estimates, raised its quarterly dividend, and provided optimistic FY2026 EPS guidance.

The Commonwealth of Pennsylvania Public School Empls Retrmt SYS reduced its holdings in BlackRock (BLK) by 2.9% in the fourth quarter. This reduction comes alongside recent stock sales by BlackRock's CEO and President. Despite these insider sales and some negative sentiment surrounding Bitcoin ETF outflows, analysts have a "Moderate Buy" consensus and a target price of $1,269.06 for BlackRock, which also reported strong earnings and declared a quarterly dividend.

Eurizon Capital SGR S.p.A. has initiated a new position in Cadence Design Systems (NASDAQ:CDNS), investing approximately $36.88 million. This move comes as other institutional investors have also adjusted their holdings in the software maker. The article also provides an overview of recent news and analyst ratings for Cadence Design Systems, highlighting both positive and negative sentiments surrounding the stock.

Regeneron Pharmaceuticals, Inc. (REGN) announced that the European Medicines Agency (EMA) has accepted for accelerated review its Marketing Authorization Application for Otarmeni. This gene therapy targets biallelic OTOF variant-associated hearing loss and, if approved, would be the first for OTOF-related hearing loss in the EU. The application is supported by data from the pivotal CHORD trial, though the company recently faced downward price target adjustments from analysts following a missed primary endpoint in a separate Phase 3 study.

GLJ Research upgraded First Solar (FSLR) to Buy from Hold, setting a price target of $315, citing resolved cancellation risks and the launch of its Series 6 CuRe technology. This follows a similar upgrade by Freedom Broker earlier in the month, which foresaw increased domestic demand due to Section 232 tariffs. First Solar reported a strong Q1 2026 with record revenue and margin expansion, benefiting from its differentiated technology and independence from Chinese supply chains.